Increased adiposity, through adipocyte hypertrophy, and/or hyperplasia, characterizes aging and obesity. Both are leptin-resistant states, associated with disturbed lipid metabolism, reduced insulin sensitivity and inflammation. Nevertheless, fat tissue dysfunction appears earlier in obesity than in normal aging. In contrast, lipodystrophy is accompanied by diabetes, and improving the fat cell capacity to expand rescues the diabetic phenotype. Fat tissue dysfunction is extensively studied in the diet-induced obesity, but remains relatively neglected in the aging-associated obesity. In the Wistar rat, as occurs in humans, early or middle aging is accompanied by an increase in adiposity. Using this experimental model, we describe the molecular mechanisms contributing to the white adipose tissue (WAT) hypertrophy. WAT from middle-old age rats is characterized by decreased basal lipogenesis and lipolysis, increased esterification, as demonstrated by the higher TAG and cholesterol content in visceral WAT, and the maintenance of total ceramide levels within normal values. In addition, we describe alterations in the adipose tissue plasma membrane lipid composition, as increased total ether-phosphatidylcholine, sphingomyelin, and free cholesterol levels that favor an enlarged fat cell size with aging. All these metabolic changes may be regarded as a survival advantage that prevents the aged rats from becoming overtly diabetic.
Since the discovery of leptin, adipose tissue has been recognized as an important and dynamic endocrine organ that regulates food intake and whole-body metabolism by secreting a variety of bioactive molecules. Major changes in adipose tissue function occur throughout life that increase disease susceptibility (1) . Specially, dysregulation of adipocyte lipid metabolism participates in the pathogenesis of obesity and aging-associated metabolic syndrome by mechanisms that are not fully understood. Fat tissue dysfunction in diet-induced obesity is extensively studied, but it remains relatively neglected in age-related obesity. While fat tissue dysfunction in obesity is associated with a shortened lifespan (1), nowadays obesity frequently accompanies aging as life expectancy increases. In fact, the maintenance of adipose tissue seems to be physiologically beneficial at advanced old age (2, 3) . Moreover, aging and obesity are both associated with some biological hallmarks related to a dysfunctional adipose tissue such as insulin resistance, chronic low-grade of inflammation, dyslipidemia, hepatic steatosis, diabetes, among others (4) . Nevertheless, while all white fat depots are increased in obesity, aging is characterized by earlier loss of subcutaneous fat and increased or unchanged visceral fat (5) . Moreover, the immune cell function is drastically different in the aging-associated obesity compared to the diet-induced one (6) .
Several groups have proposed that one of the underlying cause of obesity and aging associated-metabolic dysfunction is the loss of leptin action (ie, that the insulin-resistance syndrome is a leptin-resistance syndrome) (7) (8) (9) (10) (11) . For this reason, the relationship between obesity, leptin, and type 2 diabetes is extensively studied. The hormone leptin acts through two main pathways that are not mutually exclusive: trough the brain and directly on the peripheral tissues (liver, skeletal muscle, adipose tissue, pancreas, etc.) (12) . After a meal, the increase in plasmatic insulin promotes the secretion of leptin by adipocytes (12) . Leptin travels to the brain, acting mainly on the hypothalamus. Hypothalamic neurons transmit the signal to the rest of the brain, reducing the food intake, and through the autonomous nervous system to the peripheral organs, promoting the oxidation of lipids and carbohydrates, and improving overall insulin sensitivity (12, 13) .
Central or peripheral leptin administration has been proven to reduce adiposity, to exert antisteatotic effects on lean tissues and to increase whole-body insulin sensitivity (9, 10, 14, 15) . When leptin action is impeded, adiposity increases, and insulin resistance develops (16) . However, lipodystrophic mice models lacking functional adipocytes also present a diabetic phenotype (17) (18) (19) . Moreover, increasing the capacity of the white adipose tissue (WAT) to expand in ob/ob mice normalizes all the metabolic parameters despite the obese phenotype (20) . Additionally, in human twins discordant for obesity but still metabolically healthy, failure in the mechanisms that adapt adipocyte membranes to tissue expansion result in metabolic complications (21) . Thus, adipose tissue accretion does not always end up in a diabetic phenotype and in some cases, could even prevent diabetes onset.
Our aging model, the 24-month-old Wistar rat, presents an increased adiposity, inflammation, dyslipidemia, and liver steatosis (22) (23) (24) . These animals exhibit central leptin resistance, as evidenced by reduced hypothalamic leptin uptake (25) , decreased levels of leptin receptors, and elevated levels of the suppressor of cytokine signal (SOCS3) in the hypothalamus compared with young and lean rats (26, 27) . Furthermore, euglycemic-hyperinsulinemic clamp experiments demonstrated that old Wistar rats have overall insulin resistance (22) . However, the decreased insulin sensitivity is tissue specific, as the insulin-signaling pathway is impaired in WAT but not in liver (28) . In addition, insulin resistance as well as inflammation does not develop at the same time in all the types of adipose tissue (23) . As a result, aged Wistar rats maintain fasting serum glucose and insulin within normal levels, although they needed more insulin to normalize glucose after an oral glucose test (22) . All this body of evidence suggests that old Wistar rats are in a prediabetic state. Nevertheless, these animals die without becoming overtly diabetic.
Based on our previous data, we hypothesized that in the middleold age Wistar rat, despite mild dyslipidemia and hepatic steatosis as compared to that observed in obese diabetic 7-month-old Wistar rats (29) , the visceral adipose tissue undergoes profound metabolic and adipocyte plasma membrane (PM) lipid remodeling. The visceral adipose tissue remodeling with aging would enable the fat cell to expand, preventing excessive lipid spill-over to lean tissues and thereby diabetes onset. Hence, in this work, we studied the adaptations in adipose tissue PM lipid composition in epidydimal white adipose tissue (eWAT) from middle-old age Wistar rats by shotgun lipidomics. We also studied the expression of several enzymes and transcription factors involved in lipid metabolism, as well as the lipid contents in eWAT and serum.
Finally, we analyzed in eWAT alterations in glucose incorporation into lipids and the changes in ceramide levels and sphingolipid metabolism enzymes expression. Our results suggest some of the molecular mechanisms by which eWAT undergoes hypertrophy as a survival response that may prevent diabetes onset in the face of obesity, mild hepatic steatosis and altered central leptin responsiveness.
Methods
See Supplementary Methods for detailed experimental procedures.
Materials
All chemical reagents were purchased from commercial suppliers described in Supplementary Methods.
Animals
Three-and 24-month-old (middle-old age) male Wistar rats were handled as described in the Supplementary Material. Blood was centrifuged at 2,000g at 24°C for 15 min, serum was recovered and frozen in liquid nitrogen for stored at −70°C until use. The visceral epididymal and retroperitoneal WAT were rapidly dissected out and weighed. Visceral adiposity index, expressed as a percentage of body mass, was calculated as the sum of the weights of the epididymal and retroperitoneal fat tissues, divided by the body weight (22) . All tissues were finally flash frozen in liquid nitrogen and stored at -70°C until use for RNA or lipid extractions.
Metabolites and Hormone Levels in Serum
Metabolites and hormone levels were determined using commercially available kits are described in detail in Supplementary Methods.
Isolation of Rat Adipocytes and Metabolic Assays
Rats were fasted 16 h overnight before being anesthetized by CO 2 inhalation and sacrificed by decapitation. Adipocytes were prepared from eWAT by digestion with collagenase, suspended in 3% BSA/ Krebs-Ringer medium, pH 7.4, 25 mM HEPES, containing 2 mM glucose, and 0.25 μCi/mL of D-(U-14 C)-glucose for 1 h at 37°C, and the incorporation of glucose into CO 2 , triglycerides, and fatty acids was performed as described in Supplementary Methods. As basal lipolysis increases with the period of fasting, we decided to analyze basal glycerol and non-esterified fatty acid (NEFA) release in the incubation medium in eWAT explants from rats after 36 h fasting. The eWAT explants (100 mg) were transferred into identical fresh medium, as above, without D-(U-14 C)-glucose, and incubated for a further 3 h at 37°C. See Supplementary Methods for details.
Adipocyte Size
Adipocyte size was determined on cryostat sections of eWAT stained with hematoxylin and eosin. eWAT was obtained from 3-and 24-month-old rats previously perfused through the heart under deep anesthesia and processed as described in Supplementary Methods. After staining, fat cell Feret's diameters were determined in 4-6 sections of eWAT from 3-(n = 201 adipocytes) and 24 months (n = 205 adipocytes) old rats, respectively, using the National Institutes of Health Image J image software.
RNA Extraction and Real-Time RT-PCR
Total RNA was isolated from eWAT using the Trizol reagent (Invitrogen) following the manufacturer's instructions. The cDNA was synthesized from 1.5 μg of DNase-treated RNA by using the reverse-transcriptase activity from Moloney murine leukaemia virus (Gibco-BRL), and p[dN]6 (Boehringer Mannaheim, Germany) as random primer, and quantitative real-time PCR are described in Supplementary Methods.
eWAT Subcellular Fractionation and Immunoblot Analysis
The eWAT was homogenized and, total extracts, PM, the endoplasmic reticulum (ER), and nuclear fractions were obtained as described in Supplementary Methods. Samples were run on the same gel, immunoblotted, and detected as previously described (15, 24, 28) . Na + /K + -ATPase was used as a PM marker (Supplementary Figure 2) , GRP78 (glucose regulated protein 78) and lamin A/C were used as marker proteins for ER and nuclear fractions, respectively. β-actin was used as control of protein loading. Immunoblot analysis and antibodies used are described in Supplementary Methods.
Total Lipid Measurements in eWAT
Total lipids were extracted from 100 mg of tissues by the method of Folch (30) . TAG and the total FA (free FA and fatty acyl-CoAs) were measured using commercially available kits detailed in Supplementary Methods.
Triglycerides Fatty Acid Profile From eWAT
Total lipids were extracted from 100 mg of tissue by the method of Folch (30) , in the presence of pentadecanoic acid (C15:0) 0.7 μg/mg tissue. The lipid extract was dried-down under nitrogen, taken up in 150 uL of chloroform and applied on to Discovery-DSC-NH 2 cartridges (Supelco) previously equilibrated with 5 mL hexane. TAGs were eluted with 2 mL hexane/acetic acid (85/15, v/v), dried-down, and subjected to hydrolysis and fatty acid methylation with 2.5 mL metanol/HCl (5/1, v/v) at 75°C. After 5 h, 2 mL hexane was added, the mixture was centrifuged at 200g for 5 min at room temperature and the upper phase was dried-down. Fatty acid methyl-esters were taken-up in 0.3 mL hexane and were analyzed as previously reported (14) and detailed in Supplementary Methods.
Quantification of Lipid Species from eWAT by Quadrupole Time-Of-Flight Mass Spectrometry
Ceramides were purified from the total lipid extract by TLC (15) . Lipids from 10 μg protein of the eWAT PM fractions were extracted in the presence of internal standards SM 35:1;2 (17:0) (20 μmol/μg protein), D6-Chol (60 μmol/μg protein), and PC 36:6 (18:3/18:3) (20 μmol/μg protein) as described in (15) . For free cholesterol determination, PM lipid extracts were acetylated according to (31). A hybrid QSTAR Pulsar i mass spectrometer (MDS Sciex, Concord, Canada) equipped with an automated nanoflow ion source NanoMate HD System (Advion BioSciences, Ithaca, NJ) was operated as described in Supplementary Material. SMs and PCs in eWAT PM were quantified in positive ion mode by precursor ion scanning of the phosphorylcholine head group fragment (m/z 184.07). Spectra were interpreted using LipidProfiler software (32) . Free cholesterol and ceramides were quantified by tandem mass spectrometry using MRM approach (15) .
Central Leptin Infusion
The effects of centrally administrated leptin were performed using three groups of 3-and 24-month-old animals, randomly distributed:
(1) rats infused with leptin; (2) rats infused with vehicle and allowed to eat ad libitum; (3) rats infused with vehicle and pair-fed to the amount of food consumed by the leptin-infused animals. The third group was a control for leptin effects regardless the reduction in food intake. The intracerebroventricular leptin administration is detailed in Supplementary Methods. Food intake and body weight were measured daily. After 7 days, rats were fasted 16 h overnight before being anesthetized by CO 2 inhalation, and sacrificed by decapitation. After that, blood was removed and serum was recovered as described above. Epididymal and retroperitoneal adipose tissues were carefully dissected and weighed and the visceral adiposity index was calculated as described above.
Statistical Analysis
Statistical analysis was performed using the GraphPad Prism version 6.0 for Windows (GraphPad Software). Details are in Supplementary Methods.
Results
This work explores the metabolic and PM lipids rearrangements undergone by the rat visceral white adipose tissue as it is accumulated in the context of aging.
Middle-Old Age Rats Exhibit Increased Adiposity and Central Leptin Resistance
As expected, 24-month-old rats have increased visceral adiposity and higher serum leptin and resistin levels when compared to 3-month-old rats (Table 1) . Nevertheless, adiponectin levels did not change with aging. In agreement with our previous observations (14, 15) , intracerebroventricular leptin infusion (0.2 μg/day, 7 days) in 3-month-old rats reduced food intake, body weight, and visceral adiposity index (Supplementary Figure 1A) . However, in old animals, central leptin infusion only modestly reduced the food intake, without change in body weight, and the adiposity index (Supplementary Figure 1B) . Thus, old rats manifest limited responses to centrally infused leptin, validating our previous works implying central leptin resistance in this aging model (25, 26) . Additionally, as we described before using euglycemic-hyperinsulinemic clamp experiments, old Wistar rats present systemic insulin resistance (22) and manifest postprandial hyperglycemia after a high-fat meal (unpublished observations AF, CP, VL, NG, AA). Further, although old rats showed significant increase in serum TAG and total cholesterol levels, and mild hepatic steatosis, the animals were still able to maintain their fasting NEFA, glucose, adiponectin, and insulin levels in serum within normal levels (Table 1) . Thus, these animals constitute an aging-related pre-diabetic model. Figure 1A , according to the augmented adiposity of old rats, the adipocyte size significantly increases in 24-month-old animals. Additionally, we observed an augmented glucose conversion to fat in isolated adipocytes from old animals. Basal D-(U-14 C)-glucose oxidation to 14 CO 2 and its incorporation into TAG and fatty acids was measured over 1 h in isolated adipocytes from young and old rats. The amount of glucose incorporated into TAG-glycerol was increased almost twofold upon aging, whereas the amount of glucose incorporated into TAG-fatty acid decreased almost sevenfold, and the percentage of glucose oxidized to CO 2 did not change ( Figure 1B) . These results reflect a decrease in de novo lipogenesis (DNL), and that glucose is preferably used to generate glycerol for TAG formation, which may indicate an increased esterification capacity of this visceral adipose tissue in old rats. In fact, total TAG and cholesterol content is increased almost two-and threefold, respectively, in eWAT from 24-month-compared to 3-month-old rats ( Figure 1D ). Lipolysis may also affect fat pad size. As shown in Figure 1C , basal eWAT lipolysis decreased significantly in middle-old age rats, as demonstrated by the low levels of glycerol and NEFA released under basal conditions.
Adipocytes from Middle-Old
Age Rats are Bigger, Present Decreased De Novo Lipogenesis and Lipolysis, and Increased Esterification As shown in
Middle-Old Age Rats Have an Altered Expression of Transcription Factors and Enzymes Involved in Lipid Metabolism in eWAT
Because several metabolic functions of adipose tissue are subject to change with adipocyte size, we analyzed the expression of regulatory factors involved in lipid synthesis (SREBP-1c, ChREBP, or PPARγ), lipid oxidation (PPARα and PGC-1α), and lipolysis (Foxo1) in eWAT (Figure 2) . In old rats, the mRNA (Figure 2A ) and protein ( Figure 2D ) levels of the lipogenic transcription factor SREBP-1c were up-regulated. However, the levels of the mature form of SREBP-1c did not change in old rats ( Figure 2D ) and the expression of the other major lipogenic factor ChREBP was decreased (Figure 2A) , together with its targets, the lipogenic enzymes Scd-1, FAS, and ACC ( Figure 2B ). These results, together with the metabolic measurements described above, suggest a decrease in the DNL in eWAT from old Wistar rats.
The transcription factor Foxo1 regulates the insulin-mediated expression of adipose triglyceride lipase (ATGL), affecting thereby lipolysis in adipose tissue (33) . According to Figure 2A , the mRNA levels of Foxo1a are reduced in old animals, as are the mRNA and (D) Representative western blot and densitometry analysis of the nuclear PGC-1α as well as native and mature SREBP-1c in the endoplasmic reticulum or nucleus, respectively, from eWAT in 3-and 24-month old rats. GRP78 and lamin A/C were used as reporter proteins of ER and nuclear fractions, respectively. (F) Representative western blot and densitometry analysis of total protein levels of adipose triglyceride lipase, Plin-1, hormone sensitive lipase (HSL), as well as the phosphorylation of HSL in total extracts from eWAT. 30 µg of protein from ER, nucleus and total extracts from eWAT were used for the immunoblot analysis; β-actin was used as control of protein loading in all blots (D and F). Values are the means ± SEM of 6-8 separate determinations per group of animals (*p < .05, **p < .01 vs 3-month old rats, unpaired Student's t test).
protein levels of ATGL ( Figure 2C and F) . Moreover, the mRNA, protein, and activation levels of hormone sensitive lipase (HSL) are also decreased. These results are consistent with the decrease of basal lipolysis found in eWAT from old rats ( Figure 1C ). At the same time, the mRNA levels of DGAT-1 ( Figure 2C ), DGAT-2, and the glyceroneogenic enzyme PEPCK are up-regulated ( Figure 2E ).
On the other hand, the expression of lipoprotein lipase (LPL) and FAT/CD36, the main coordinators of circulating lipoprotein hydrolysis and cellular uptake of FFAs, were up-regulated in old rats ( Figure 2B) . Moreover, the mRNA and protein levels of Plin1, a major regulator of lipid droplet expansion, were either increased ( Figure 2B ) or unchanged ( Figure 2F ), respectively, in middle-old age rats. Also, the mRNA and protein levels of PGC-1α, a factor that favors thermogenesis and fatty acid β-oxidation, was down-regulated (Figure 2A and D) . However, neither the mRNA levels of the transcription factor PPARα involved in lipid oxidation (Figure 2A ), nor their target gene CPT-1b were altered in aged animals ( Figure 2B ). Altogether, these data support the increased adipocyte size and esterification found in old animals ( Figure 1A , B and D).
White Adipose Tissue and TAG Fatty Acid Profile is Altered in Middle-Old Age Rats
We next analyzed the impact of the metabolic changes undergone by eWAT in aged rats on the fatty acid composition of TAG in this tissue. To that end, total lipids were analyzed by gas chromatography. In the aged animals, we observed a marked decrease in shorter longchain saturated fatty acids (Table 2) , in line with their reduced DNL. The proportion of the insulin-sensitizing lipokine C16:1n7 (34) was also reduced (Table 2) . On the other hand, there was an increase in the levels of linoleic and oleic acids ( Table 2) .
Adipose Tissue PM Lipid Composition is Altered in Middle-Old Age Rats
Adipose cell expansion must constitute a challenge for its PM integrity and functionality. Hence, we next investigated if the PM lipid composition has undergone any change in the hypertrophied adipocytes from the old rats. We applied a shotgun lipidomics approach in positive ion mode to quantify the major PM phospholipid classes such as phosphatidylcholines, ether-phosphatidylcholines, sphingomyelins, and free cholesterol. As shown in Figure 3 , although the total amounts of PC ( Figure 3A ) did not change in eWAT PM with age, total ether-PC (Figure 3B), SM (Figure 3C) , and free cholesterol ( Figure 3D ) levels of aged animals were increased compared to the young ones. SM and free cholesterol are packed at a higher density than glycerolipids due to their matching geometry and resist much better mechanical stress, favoring thereby bigger cell size.
In addition, we investigated if the fatty acid-specific SM, PC, and ether-PC species in the adipose tissue PM were altered in old rats. As shown in Figure 3E -G, the main characteristic of the aged animals is an elevation in the fatty acids desaturation (SM40:2, PC34:2, PC36:3, PC36:2, PC-O-34:1, PC-O-36:2, and PC-O-36:1), a shift towards short chain species (SM34:1, PC32:0, and PC-O-32:0) and a reduction in PUFA-containing PC38:4. All these alterations probably result in changes in membrane fluidity, thickness, and mechanical resistance (35) and might be regarded as adaptations to maintain the adipocyte PM functionality as the cell expands.
Ceramide Species Relative Abundance in eWAT is Altered in Middle-Old Age Rats, But Not Total Ceramide Levels
Ceramide is a biologically active lipid involved in lipoapoptosis of non-adipose tissues subjected to lipid overload (36) . In a previous Note: TAG from total eWAT chloroformic extracts were purified by solid phase extraction and quantified by gas chromatography using C15:0 as internal standard. Values are the means ± SEM of 4-6 separate determinations per group of animals, each one made in duplicate (*p < .05, **p < .01, ***p < .001 vs 3 m; unpaired Student's t test). work, we demonstrated that central leptin, acting through the autonomic nervous system, lowered ceramide levels in eWAT from 3-month-old Wistar rats, probably preventing thereby the development of the chronic inflammatory state that characterizes obesity (15) . Here, using central leptin-resistant pre-diabetic rats, we studied ceramide contents and the expression of enzymes from ceramide metabolism in eWAT.
The enzymes involved in de novo ceramide synthesis such as the rate limiting SPT and LASS6, are up-regulated in eWAT in old rats ( Figure 4A ). This, together with an increased lipid supply from plasma (Table 1) , would favor de novo ceramide synthesis in old rats. On the other hand, the sphingomyelinase SMPD-2 expression was decreased in aged rats (Figure 4A) , suggesting a reduction in ceramide production from SM. Additionally, the mRNA levels of the ceramidase Asah1 were up-regulated ( Figure 4B ), indicating an augmented hydrolysis of ceramides. As a result, total ceramide contents in eWAT did not increase upon aging (Figure 4C ), although their fatty acid profile shifted towards Cer16:0 ( Figure 4D ), according to the changes in SPT1 and LASS6 expression ( Figure 4A ). In addition, we found that the ratio Cer24:0/Cer24:1 increased with aging ( Figure 4D ), according to the changes in Scd-1 expression ( Figure 2B ).
Discussion
Several experimental evidences show that upon aging the peripheral insulin resistance built-up does not occur at the same time in all insulin target tissues. Although the skeletal muscle was proposed as the primary site for the whole-body insulin resistance development, previous results from our group support the notion that upon aging insulin resistance develops first in WAT, whereas other peripheral tissues still respond normally to insulin (22) . Moreover, there is compelling evidence suggesting that leptin resistance precedes the instauration of insulin resistance (11).
It is widely accepted that after insulin resistance development in WAT and/or skeletal muscle, there must be a rise in plasmatic NEFA before hyperglycemia onset. Increased plasmatic NEFA impair insulin ability to inhibit hepatic glucose output, and stimulate insulin secretion by pancreatic β-cells, resulting in compensated hyperinsulinemia. However, sustained exposition to increased plasmatic NEFA levels, leads to apoptosis of pancreatic cells, resulting in a drop of insulin levels in plasma, and consequently, in fasting hyperglycemia (37) . Nonetheless, it is now clear that insulin resistance can develop in obesity without elevation of NEFA concentrations (38) .
Maximal life span of male Wistar rats is about 32-34 months, while mean life span is about 24 months (39). Thus, the 24-month-old rats used in the present study are middle-old age animals. At this age, an according to our previous observations (22) (23) (24) (25) (26) visceral adiposity, adipocyte size in eWAT, and total body fat mass increase (22, 23) . On the other hand, there is a decrease in adiposity and adipocyte size in advanced-old age rats (3, 5) . 24-month-old Wistar rats are leptinresistant at the central level, as demonstrated by our previous (25, 26) and present data, where central leptin injections fail to exert its usual anorexic and adipostatic effects (10, 14, 15) . In addition, old rats exhibit an augmented content of lipids in liver (24) , indicating that NEFAs are accumulated in the non-fat tissues. Consequently, old rats are hypertriglyceridemic and hypercholesterolemic, and manifest systemic and cellular insulin resistance (22, 23, 28) . All together, these data support the notion that a normal leptin signaling through the brain is needed to prevent an increased adiposity and to maintain the wholebody insulin sensitivity. However, central leptin-resistant Wistar rats are still able to maintain their fasting NEFA, glucose and insulin levels in plasma within normal values, and die without becoming overtly diabetic, that is, hyperglycemic. Hence, the 24-month-old, middle-old age, Wistar rats constitute an interesting model to study the mechanisms preventing diabetes development in the face of aging-associated augmented adiposity, mild dyslipidemia, and hepatic steatosis.
With this regard, lipodystrophy is also associated with diabetic phenotype (7, 17, 19) and there is an increasing number of evidence indicating that favoring the fat cell capacity to augment its size protects against diabetes (20) . Thus, several lines of evidence suggest that upon aging, Wistar rats develop compensatory mechanisms in the white adipose tissue that prevent the onset of diabetes. First, to reduce the lipid spillover from eWAT to lean tissues, lipoprotein lipolysis, and cellular uptake of FFAs are increased, as evidenced by the up-regulated expression of LPL and CD36 in this tissue upon aging. Second, the down-regulation of mRNA and protein levels of ATGL and HSL, as well as reduced basal activation/phosphorylation of HSL suggest that basal lipid droplet lipolysis seems to be repressed in eWAT from old rats. Third, we found that Plin-1 mRNA and protein levels are either increased or unchanged at 24 months of age. Hence, according to publish data (40) , perilipin 1 may act protecting lipid droplets from lipases under basal conditions. On the other hand, the augmented incorporation of glucose into glycerol-TAG, the increased expression of the glyceroneogenic enzyme PEPCK, and the up-regulation of the mRNA levels of DGAT1 and DGAT2 suggest that the esterification is up-regulated in eWAT of aged rats. In this sense, overexpression of DGAT2 in hypertrophic 3T3-L1 adipocytes is associated with attenuated leptin action (41) and with large lipid droplets accumulation in mouse (42) . Thus, our data indicate that DGAT2 could be involved in the physiological process of enlarging adipocytes in older animals. Thus, as occurs in WAT of insulin-resistant humans (43), we found decreased basal lipolysis and increased esterification in 24-month-old age Wistar rats.
Additionally, our results indicate that DNL in eWAT is decreased in old Wistar rats, concurrently with other obese or aged insulin-resistant rodents (22, 44) . Thus, the expression of ChREBP, is downregulated, the proteolytic maturation of SREBP-1c is impaired and, consequently, the expression of DNL enzymes is markedly suppressed in these hyperleptinemic animals. Moreover, previous results from our group (9, 10) have demonstrated that hyperleptinemia, probably through SOCS3 increase, induces insulin resistance to eWAT, which could most likely contribute to down-regulate DNL in this tissue of aged rats. The reduced DNL is also reflected in the TAG fatty acid profile, where the proportion of shorter long-chain saturated species (14:0, 16:0) is reduced in old Wistar rats with bigger adipocytes, as well as that of the insulin-sensitizing factor 16:1,n7, suggesting as in humans that DNL is downregulated as adipocytes expand (45) .
Additionally, to increase its storing capacity, the fat cell size of old rats gets bigger by several mechanisms. On one hand, the adipocyte PM undergoes adaptive changes to be able to cope with the fat cell expansion and at the same time maintain its functionality. Although for a bigger fat cell more phospholipids should be needed, the alterations observed are very specific for a given lipid specie. In fact, there is a clear shift towards desaturated and short-chain species in PC and ether-PC species, even though the levels of total PC, one of the most abundant phospholipids from the PM, do not change. Nevertheless, total ether-PC increased and this has been associated with the expansion of white adipose tissue of obese humans (21) . A similar result was observed for the SM fatty acid profile. Interestingly, alterations in the fatty acid profile of adipose tissue PM phospholipids are opposite to the ones observed for TAG and the endogenous de novo fatty acid synthesis. This result suggests that TAG and PM phospholipids could have two different sources of fatty acids. In addition, the levels of total SM and free cholesterol are increased in old rats, probably favoring more mechanically resistant structures and a bigger membrane area.
Although in old rats the pathway for de novo ceramide synthesis is strongly fueled-up, the increase in eWAT ceramide levels is impaired. This process might protect adipocytes from lipoapoptosis and contribute to their hypertrophy. In addition, the presence of esterified saturated fatty acids in ceramides from eWAT is increased, in particular the product of LASS6 and LASS2 (ceramide synthase 6 and 2) Cer16:0 and Cer20:0, respectively. Increased LASS6 expression and Cer16:0 levels have been reported in adipose tissue of obese humans, and correlates with insulin resistance (46) . Therefore, our data suggest that the change in ceramides species in the absence of alterations in total ceramide levels seems to be important for the aging-associated adipose tissue hypertrophy. It might also be protective against anoxic injury and exaggerated inflammatory responses occurring in eWAT because of adipose tissue accretion.
Finally, since the ability of the adipose tissue to buffer variations in lipid supply and demand is achieved through dynamic changes in cellular composition, we can speculate that, over the time, aged Wistar rats were changing its adipocyte size and membrane lipid composition in eWAT in order to accommodate the excess fat transported by lipoproteins. Nevertheless, the expandability of any adipose tissue depot is not an unlimited process (47) , hence, eventually; the adipose tissue could be unable to store excess lipids. In conclusion, our results describe some of the molecular mechanisms behind WAT expansion with age that could constitute a possible survival mechanism preventing diabetes onset in the context of mild hepatic steatosis. Our hypothesis agrees with the "adipose tissue expandability model" proposed by Vidal-Puig's group for humans and rodents, stating that hypertrophy preferentially occurs in the visceral adipose tissue, while hyperplasia is more characteristic of the subcutaneous one (47, 48) . Although our study is performed in a rat pre-diabetic model, it also might provide clues about treatment of obesity-related metabolic complications in humans as they age.
Supplementary Material
Supplementary data is available at The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences online.
Funding
This work was supported by the Junta de Comunidades de Castilla-La Mancha (grant numbers PCI08-0136, PEII-2014-022-P); and the Ministerio de Ciencia e Innovación, Spain (grant number BFU2012-39705-C03-01).
